CATALIST-LISTED Hyphens Pharma has inked an exclusive licensing deal to commercialize an antibody biosimilar drug in Singapore, Malaysia, and the Philippines, in order to expand their dermatology ...
网页链接CATALIST-LISTED Hyphens Pharma has inked an exclusive licensing deal to commercialize an antibody biosimilar drug in Singapore, Malaysia, and the Philippines, in order to expand their dermatology ...
网页链接
精彩评论